BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.

PHASE3CompletedINTERVENTIONAL

Enrollment

268

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Obstructive Sleep ApneaExcessive Daytime Sleepiness

Interventions

DRUG

BF2.649

1 capsule per day in the morning before the breakfast

DRUG

Placebo

1 capsule per day in the morning before the breakfast

Trial Locations (1)

Centre Hospitalier Universitaire de Grenoble, Grenoble